DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Cataldo NA, Abbasi F, McLaughlin TL, Basina M, Fechner PY, Giudice LC, Reaven GM.
Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome.
Hum Reprod 2006; 21: 109-120
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.